Cerapedics Board of Directors
Jonathan Silverstein, JD
Mr. Silverstein is a Partner and Co-Head of Global Private Equity with OrbiMed, a leading investment firm dedicated exclusively to the healthcare sector and holding over $14 billion in assets under management.
Glen has over 30 years of executive management experience within market leading device companies. Prior to becoming CEO in 2013, Glen served as Worldwide President of Spine & Bone Healing Technologies, Inc., a Biomet company, and concurrently served as Senior Vice President on Biomet’s Worldwide Operating Board, encompassing Biomet’s orthopedics, spine, trauma, biologics and sports medicine businesses. He also served as Worldwide President for Biomet Spine and Trauma. During his tenure at Biomet, he launched more than 25 new products. Prior to Biomet, Glen held a number of division president roles at Johnson & Johnson, including Worldwide President of Cordis Endovascular, Cordis Neurovascular and Codman Neuro Sciences, and U.S. President of DePuy Spine.
Antony Koblish is a medical device entrepreneur with 25 years of experience in healthcare. He is a co-founder, President, and CEO of TELA Bio, a biosurgical reconstruction company based in Malvern, Pennsylvania. Prior to founding TELA Bio, he was President and CEO of Orthovita, a publicly traded orthobiologics and biosurgery medical device company. During his tenure as CEO of Orthovita, he created significant company value, growing valuation from $30 million to a $316 million exit sale to Stryker Corporation in May 2011.
Han Lee, PhD
Han Lee is currently a Senior Director within AstraZeneca’s Corporate Development and Ventures group, having responsibility for mergers and acquisitions, transformative deals, and strategic equity investments. Prior to AstraZeneca, Han was an integral part of two biotech start-ups that both had successful exits and was a part of entrepreneurial teams that have raised over $100 million in financing deals. Han received his BA in Genetics and minor in Chemistry from the University of California, Berkeley. He received his PhD in Genetics and MBA from Yale University.
Mr. Kroloff is a Partner of NGN Capital, a venture capital firm dedicated to healthcare investing and focusing on ventures with the potential to achieve above average private equity returns and an emphasis on later stage investments.
Mr. Khuong is a Private Equity Partner with OrbiMed, a leading investment firm dedicated exclusively to the healthcare sector and holding over $14 billion in assets under management.
Andrew Tofe, PhD
Dr. Tofe is the founder and former CEO of Cerapedics.
Mr. Abramowitz is a Co-Founder and Managing General Partner of NGN Capital, a venture capital firm dedicated to healthcare investing and focusing on ventures with the potential to achieve above average private equity returns and an emphasis on later stage investments.